Fut, nem toborozFázis nélkül
BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery
A legfontosabb adatok
- Ki végzi
- University of Leipzig
- Hol
- Németország1 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 120 fő, tervezett
- Kezdés
- 2019. jan. 1.
- Befejezés
- 2026. júl.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoport
- A vizsgált kezelések
- Stent-avoiding
- Stent-based
- A regiszteradat frissítve
- 2026. május 6.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 29 feltétel megnézéseKevesebb
Ki vehet részt
- Subject age ≥ 18
- Subject has been informed of the nature of the study, agrees to participate, and has signed a Medical Ethics Committee approved consent form Subject understands the duration of the study, agrees to attend follow-up visits, and agrees to complete the required testing
- Subject has a de novo or restenotic lesion with ≥ 70% stenosis documented angiographically and no prior stent in the target lesion
- Rutherford Becker Classification 2-4
- Both treatment options seem feasible at the operator's discretion
- Femoropopliteal lesions classified as TASC II Type B-D with a maximum lesion length ≤ 30cm not involving the infrageniculate popliteal artery are eligible
- Reference vessel diameter (RVD) ≥ 4 mm and ≤ 6.5 mm by visual estimation
- Patency of at least one (1) infrapopliteal artery to the ankle (< 50% diameter stenosis) in continuity with the native femoropopliteal artery. The inflow artery(ies) cannot be treated using a drug eluting stent or drug coated balloon
- A guidewire has successfully traversed the target treatment segment
Ki nem vehet részt
- Prior vascular surgery of the target lesion
- Stroke or heart attack within 3 months prior to enrollment
- Any planned surgical procedure or intervention performed within 30 days prior to or post index procedure
- Enrolled in another investigational drug, device or biologic study that interferes with the study
- Known allergies or sensitivity to heparin, aspirin, other anticoagulant/ antiplatelet therapies, paclitaxel or contrast media that cannot be adequately pre-treated prior to index procedure
- Receiving dialysis or immunosuppressant therapy
- Failure to successfully cross the target lesion
- SFA or PPA disease in the opposite leg that requires treatment at the index procedure
- History of major amputation in the same limb as the target lesion
- Significant gastrointestinal bleeding or any coagulopathy that would contraindicate the use of anti-platelet therapy
- Platelet count <100,000 mm3 or >600,000 mm3
- Chronic kidney disease (serum creatinine > 3 mg/dL)
- Angiographic evidence of severe calcification that makes a stent-avoiding approach not feasible at the operator's discretion
- Femoropopliteal lesions classified as TASC II Typ A (single stenosis >=10cm and single occlusion >=5cm)
- Presence of fresh thrombus in the lesion
- Presence of aneurysm in the target vessel/s
- Presence of a stent in the target lesion
- Life expectancy of less than one year
- Rutherford classification of 0, 1, 5 or 6
- Pregnant or lactating females
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
Prospective, multi-center 1:1 randomized trial to compare efficacy and safety of a stent-avoiding (using drug coated balloons) versus a stent-preferred (using drug eluting or interwoven stents) approach for treatment of complex femoropopliteal lesions TASC II (TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease) Type B-D (stenosis >10cm, occlusions >5cm).
A vizsgálat 2 csoportja
- Stent-avoiding approachEgyéb csoport
using clinically proven drug coated balloons
Kezelés: Stent-avoiding
- Stent-based approachEgyéb csoport
using drug eluting nitinol stents. Interwoven nitinol stents in heavily calcified lesions at the operator's discretion.
Kezelés: Stent-based
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- BEST SFA Pilot Study - Best Endovascular STrategy for Complex Lesions of the Superficial Femoral Artery Comparing a Stent-avoiding (Study Arm) Versus Stent-preferred (Control Arm) Approach Within a Prospective, Randomized, Multi-center Trial
- Publikációk
- Randomized Trial Comparing a Stent-Avoiding With a Stent-Preferred Strategy in Complex Femoropopliteal Lesions.JACC. Cardiovascular interventions, 2024
- A regiszteradat frissítve
- 2026. május 6.